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Cross talk between serum Kisspeptin-Leptin 
during assisted reproduction techniques
Rehana Rehman1, Zehra Jamil2, 
Aqsa Khalid3, Syeda Sadia Fatima4 
ABSTRACT
Background & objective: Leptin facilitates onset of puberty by impact on hypothalamic Kisspeptin, 
gonadotropin releasing hormone, follicle stimulating and luteinizing hormone. The link of peripheral 
Leptin-Kisspeptin in regulating the ovarian and endometrial tissue in relation to adiposity is unknown. 
Therefore, we wanted to identify Kisspeptin-Leptin association with body mass index (BMI) and success of 
assisted reproductive treatments (ART) in infertile females.
Methods: A cross sectional study was carried from August 2015 till May 2017 after receiving ethical approval 
at Australian Concept Infertility Medical Centre, and Aga Khan University. The study group comprised 
of females with an age range of 25-37 year who had duration of unexplained infertility for more than 
two years. They were grouped as; underweight (<18 kg/m2), normal weight (18-22.9 kg/m2), overweight 
23-24.99 kg/m2 and obese (>25 kg/m2). Kisspeptin and Leptin levels were measured by enzyme linked 
immune sorbent assay before down regulation of ovaries and initiation of treatment protocol of ART.Failure 
of procedure was detected by beta human chorionic gonadotropin <25mIU/ml (non-pregnant) whereas 
females with levels >25mIU/ml and cardiac activity on trans-vaginal scan were declared pregnant.
Results: Highest Kisspeptin and Leptin levels were seen in normal weight group (374.80 ± 185.08ng/L; 12.78 
± 6.8 pg/ml) respectively, yet the highest number of clinical pregnancy was observed in overweight group 
(42%).A strong correlation of Kisspeptin with Leptin (r=0.794, p=0.001) was observed in the overweight 
females.
Conclusion: Leptin-Kisspeptin-fertility link is expressed by maximum number of clinical pregnancies in the 
female group that showed strongest relationship between serum Leptin and Kisspeptin levels, irrespective 
of their BMI. 
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INTRODUCTION
 A person’s body weight, fat content and overall 
metabolic state are pertinent modifiers for puberty 
and fertility.1 Metabolic stress in terms of over 
nutrition and under nutrition is frequently linked 
to reproductive disorders.2 The connection between 
energy balance and reproduction are linked with 
the discovery of adipocytokine however, our 
understanding of the neurobiological basis for this 
phenomenon is still incomplete.
 Adipokines i.e. cytokine/hormones or enzymes 
secreted form adipose tissue are now considered 
as a missing link. A vast majority of adipokines 
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do not act on the hypothalamic-pituitary-gonadal 
axis (HPG axis), yet their role in reproductive 
functions along with metabolic regulations has 
great potential. One such exceptional adipokine 
famous for its dualism is ‘Leptin’ which is secreted 
by both the adipose tissue and endometrial cells.3 
Its role in obesity and reproductive regulation are 
well known.4 It appears to function as regulator of 
food quantity consumed relative to the amount of 
energy expended.5
 Kisspeptin (KP), an RF-amide coded by the 
KISS1 gene is a major neuroendocrine regulator 
of reproduction, that intricacies between central, 
peripheral reproductive-neuro-endocrine axis.6,7 
It plays a focal part in the control of the HPG axis 
neuronal activity (highly sensitive to the body energy 
stores and nutritional status) to trigger puberty 
as well as affects fertility.7,8 KP not only triggers 
onset of puberty but also relays information about 
body’s energy stores to the central nervous system 
by modulating negative and positive feedback of 
gonadal steroids.9 The expression of KISS1 is thus 
influenced by nutritional status where KP neurons 
function as a gatekeeper of reproductive function 
at pivotal times in the human lifespan, down-
regulating fertility at times of physical strain such 
as over-exercise or weight loss.10 
 The Leptin-KP harmony lies in the source and 
target as in ‘Hypothalamic neurons’, where they 
cross talk with anorexigenic pro-opiomelanocortin 
and orexigenic neuropeptide Y neurons.11,12 
Furthermore, presence of Leptin receptor (Ob-Rb) 
on KP neurons in the mouse arcuate nucleus,13 
suggests a role for KP in mediating the metabolic 
signals of Leptin on the HPG axis. These interactions 
of metabolic and KP signaling in the hypothalamic 
networks are proven, yet little explanation on 
their existence in the periphery is available.14 Both 
Leptin and KP are linked to regulation of energy 
metabolism and reproduction;15 though, the 
interactions of these hormones with infertility and 
the treatment outcomes remain unclear. Being aware 
of the presence of peripheral receptors of Leptin 
and KP, we wanted to explore the association of 
serum Leptin, KP and Body Mass Index on success 
after assisted reproductive treatment (ART) after 
suppression of HPG axis.
METHODS
 A cross sectional study was carried from August 
2015 till May 2017 after receiving ethical approval at 
Australian Concept Infertility Medical Centre, and 
Aga Khan University. The study group comprised 
of females with an age range of 25-37 year who had 
duration of unexplained infertility for more than 
two years. The decision for unexplained infertility 
was made following established protocol;16 that 
states that the diagnosis of unexplained infertility 
can be made only after excluding common causes 
of infertility using standard fertility investigations, 
which include semen analysis, assessment of 
ovulation, and tubal patency test. Females with 
known causes of infertility like polycystic ovaries, 
uterine fibroids, male factor and other metabolic 
disorders were excluded from the study. The study 
subjects were categorized as underweight (<18.5 kg/
m2), normal weight (18.5–22.9 kg/m2), overweight 
(23.0–24.9 kg/m2) and obese (≥25 kg/m2) based 
on the guidelines for South Asian population. 
Long protocol of down regulation of ovaries was 
achieved by sub cutaneous administration of 1 
mg of subcutaneous Buserelin Acetate (Suprefact, 
Sanofi Aventis, Pakistan) in mid luteal phase of 
previous cycle. Down regulation of ovaries was 
confirmed by a trans vaginal scan (TVS) which 
showed a thin endometrial lining and quiet ovaries 
without any cyst and blood test with estradiol levels 
below 30pg/ml. Five millilitres of fasting blood 
sample was collected from each subject after down 
regulation of ovaries in order to estimate Serum KP 
and Leptin levels by commercially available ELISA 
Kit (Cat.No:YHB1811Hu; Cat. No ADI-900-028A) 
following the manufacturer’s protocol.
 Controlled ovarian stimulation (COS) was 
carried out by using subcutaneous administration 
of recombinant FSH (r FSH) 50 IU preparation 
(Puregon registered; NV Organon, Oss, The 
Netherlands). The initiation dose was calculated 
on the basis of age of the subject, basal serum FSH 
concentrations, AFC and BMI. Dose was later 
adjusted by follicular tracking with TVS (7.5 MHz 
probe Aloka 500, Tokyo Japan) from the fifth day 
of COS on alternate days. COS was followed by, 
proper timing for hCG administration (ovulation 
induction),oocytes retrieval, followed by in vitro 
fertilization (IVF).(6) Failure of procedure was 
detected by beta human chorionic gonadotropin 
<25mIU/ml (non-pregnant) whereas females with 
levels >25mIU/ml and cardiac activity on trans-
vaginal scan were declared pregnant.
 Data was analysed using SPSS 21. Descriptive 
analysis of variables was expressed as mean ± 
standard deviation. Independent t test and one 
way analysis of variance (ANOVA) were used to 
compare continuous variable wherever applicable. 
Pearson correlation was applied to test the link 
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between KP-Leptin and clinical pregnancy or BMI. 
Receiver operating curve was plotted to see the 
difference between groups. In all cases a p value of 
< 0.05 was considered as significant.
RESULTS
 Hormonal analysis of one hundred and thirty-two 
infertile females was included in this study. Overall, 
the mean age and BMI of the study population was 
32.12 ± 4.7 year and 24.19 ± 3.56 kg/m2 respectively. 
Table-I segregates the study cohort on the bases 
of pregnancy outcomes that showed no difference 
in the age, BMI, follicle stimulating hormone 
(FSH) and luteinizing hormone (LH) whereas the 
variation in levels of KP, Leptin and estradiol was 
observed to be highly significant (p= 0.001, 0.025 & 
0.001 respectively).
 Levels of serum KP and Leptin were observed to 
be highest in the normal weight group (p = 0.001 
and 0.002 respectively). Regarding serum KP, post-
hoc analysis reported a significant difference in the 
normal weight group in comparison to overweight 
and obese population (p<0.01). Likewise, serum 
Leptin was also found to be significantly higher 
in the normal weight group in comparison to 
other three groups. However, while analyzing 
the implantation rate of embryo, the overweight 
group reported maximum success rate followed by 
underweight group (Table-II).
 Next, serum KP and Leptin were analyzed by 
receiver operating characteristic (ROC) curve in 
the females who achieved clinical pregnancy to 
compare their relevance to positive outcomes 
(Fig.1). Area under the curve (AUC) for KP was 
found greater (AUC= 0.786; 95% CI 0.697-0.876) 
as compared to Leptin (AUC=0.663; 95% CI 0.560-
0.765). 
 In order to gain insight, we studied correlation 
of serum KP with the levels of Leptin in clinical 
pregnancy group as well as no conception group. 
We observed a highly significant moderately 
positive correlation of KP-Lpetin in the clinical 
pregnancy group (r=0.540; p<0.001). On the 
other hand non-significant correlation was seen 
in the non-pregnancy group (r=0.110; p=0.287). 
Leptin - Kisspeptin-Fertility
Table-I: Descriptive analyses of variables 
on the basis of Pregnancy outcomes.
Variable Clinical pregnancy No pregnancy
 n=31(Group A) n=101 (Group B)
 Mean ± SD Mean ± SD
Age (year) 32.31 ± 5.1 32.06 ± 4.5
BMI (kg/m2) 23.11 ± 3.33* 24.60 ± 3.57
Kisspeptin (ng/L) 369.87 ± 138.47* 221.39 ± 96.27
Leptin (ng/ml) 11.57 ± 6.2** 8.80 ± 5.2
FSH (IU/L) 6.31 ± 0.89 6.14 ± 0.87
LH (IU/L) 6.04 ± 1.3 5.16 ± 1.05
Estradiol pg/ml 250.28 ± 68.9** 150.4± 36.02
No. of 6.61 ± 1.15* 5.79 ± 1.2
  fertilized oocytes 
No. of 1.80 ± 0.62 1.60 ± 0.57
  transferred embryo 
Endometrial 11.30 ± 2.1** 6.9 ± 2.8
  thickness (mm) 
Where: LH (luteinizing hormone), FSH (follicular 
stimulating hormone), BMI (body mass index).
T-test was applied to calculate difference between groups. 
*p-value of <0.05, ** p-value of <0.01.
Table-II: Descriptive statistics of study population categorized on the basis of BMI.
Variable Underweight Normal weight Overweight Obese
 (<18 kg/m2) (18-23 kg/m2) (23-25 kg/m2) (> 25 kg/m2)
 Mean ± SD Mean ± SD Mean ± SD Mean ± SD
 n = 22 n =37 n =24 n = 49
Age (year) 31.37 ± 3.9 30.45 ± 4.7 31.79 ± 4.6 32.36 ± 3.5
Kisspeptin(ng/L) 271.03 ± 180 374.80 ± 185.08* 245.15 ± 96.14 196.03 ± 83.08
Leptin (ng/ml) 7.29 ± 1.5 12.78 ± 6.8* 9.08 ± 5.77 8.12 ± 6.16
FSH (IU/L) 6.53 ± 0.74 6.34 ± 1.02 5.94 ± 0.97 6.12 ± 0.73
LH (IU/L) 4.91 ± 0.97 5.58 ± 1.21 6.02 ± 1.06 4.97 ± 1.19
Estradiol (pg/ml) 214 ± 45.01 180 ± 69.40 221.88 ± 75.72 150.23 ± 64.82
No. of oocytes fertilized 5.75 ± 1.2 5.86 ± 1.58 6.29 ± 1.26 6.05 ± 1.08
No. of transferred embryo 1.41 ± 0.51 1.56 ± 0.55 1.66 ± 0.56 1.7 ± 0.62
Implantation rate 29.17 ± 15.01 24.77 ± 6.86 34.03 ± 23.81 16.67 ± 14.47
Clinical pregnancy 37 % 29 % 42 % 19 %
No pregnancy 63 % 71 % 58 % 81 %
Where: LH (luteinizing hormone), FSH (follicular stimulating hormone),
BMI (body mass index) Data is expressed as Mean ± SD, or percentages. * p<0.05)
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Interestingly, overweight (r=0.794; p=0.001) 
and underweight (r=0.841; p=0.001) group, that 
reported highest clinical pregnancy were found to 
have better correlation among the two hormones 
as compared to normal weight group (r=0.233; 
p=0.166) and obese (r=0.082; p=0.538).
DISCUSSION
 High prevalence of infertility and the related issues 
has directed couples towards assisted reproductive 
techniques (ART) in our group of population.17,18 
Human reproductive function is influenced by 
a balanced relationship between key hormones 
associated with metabolic status and reproduction. 
Low KP levels were observed in our obese cohort 
that can be compared with studies done in obese 
poly cystic and pre- eclamptic females.19,20
 Observational studies have demonstrated that 
states of Leptin excess, deficiency, or resistance can 
be associated with abnormal reproductive function. 
In our study the high circulatory levels of Leptin in 
clinical pregnancy in comparison to non-pregnant 
group, has been observed by previous researchers 
where circulatory levels were related to repeated 
spontaneous abortions and higher levels with 
superior implantation success rates.21,22
 Thus, we can speculate that Leptin-KP interplay 
in the central nervous system is responsible for 
reproductive deficits associated with Leptin-
deficient states due to diminished expression of 
Kiss1. KP signaling at the same time is also shown 
to influence body weight, energy expenditure, and 
glucose homeostasis in a sexually dimorphic and 
partially sex steroid–independent manner.23,24 
 As far as BMI is concerned, a cut off value of 
less than 26 kg/m2 was associated with positive 
pregnancy outcome in our population.25 We also 
observed maximum clinical pregnancies (42%) in 
females with BMI 23-24.9 kg/m.2 As far as interplay 
of KP- Leptin and BMI is concerned, the group 
although had low Leptin and KP levels yet a strong 
significant positive correlation was observed. These 
facts support our notion that correlation between 
hormones is more critical than their mere normal 
level. This observation in the present study supports 
the role of Leptin-KP on ovarian and endometrial 
functions which is reinforced by the presence of 
Leptin receptors on these tissues. Despite these 
promising results, our study is limited in a way 
that we were unable to collect multi centre data. 
Moreover, Leptin concentration should ideally 
be performed in follicular fluid in addition to the 
serum level.
CONCLUSION
 A greater reproductive potential was observed 
in the group of females that exhibited strong 
association of Leptin with KP. Whether this link 
is predominantly permissive for diagnostic value, 
further in-depth exploration of the interplay of 
“Leptin-Obesity-Kisspeptin-Fertility” at molecular 
levels is expected to shed light in future. 
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